Chen YC - Search Results

1

PROPEL: a randomized trial of mericitabine plus peginterferon alpha-2a/ribavirin therapy in treatment-naïve HCV genotype 1/4 patients.

Wedemeyer H, Jensen D, Herring R Jr, Ferenci P, Ma MM, Zeuzem S, Rodriguez-Torres M, Bzowej N, Pockros P, Vierling J, Ipe D, Munson ML, Chen YC, Najera I, Thommes J; PROPEL Investigators. Wedemeyer H, et al. Among authors: chen yc. Hepatology. 2013 Aug;58(2):524-37. doi: 10.1002/hep.26274. Epub 2013 Jun 26. Hepatology. 2013. PMID: 23348636 Clinical Trial.

2

JUMP-C: a randomized trial of mericitabine plus pegylated interferon alpha-2a/ribavirin for 24 weeks in treatment-naïve HCV genotype 1/4 patients.

Pockros PJ, Jensen D, Tsai N, Taylor R, Ramji A, Cooper C, Dickson R, Tice A, Kulkarni R, Vierling JM, Lou Munson M, Chen YC, Najera I, Thommes J; JUMP-C Investigators. Pockros PJ, et al. Among authors: chen yc. Hepatology. 2013 Aug;58(2):514-23. doi: 10.1002/hep.26275. Epub 2013 Jun 24. Hepatology. 2013. PMID: 23359491 Clinical Trial.

3

Understanding the effect of the HCV polymerase inhibitor mericitabine on early viral kinetics in the phase 2 JUMP-C and PROPEL studies.

Chen YC, Bernaards C, Kulkarni R, Moreira S, Zhu Y, Chan A, Badman E, Ackrill A, Thommes J, Smith PF. Chen YC, et al. Br J Clin Pharmacol. 2014 Sep;78(3):533-42. doi: 10.1111/bcp.12369. Br J Clin Pharmacol. 2014. PMID: 24602156 Free PMC article.

4

The effect of mild to moderate renal impairment on the pharmacokinetics of the nucleoside analog hepatitis C virus polymerase inhibitor mericitabine.

Haznedar J, Moreira S, Marbury T, Robson R, Smith W, Kulkarni R, Munson ML, Thommes JA, Lemenuel-Diot A, Washington C, Smith P, Chen YC. Haznedar J, et al. Among authors: chen yc. Drug Dev Res. 2014 Mar;75(2):107-13. doi: 10.1002/ddr.21166. Epub 2013 Dec 26. Drug Dev Res. 2014. PMID: 24648253 Clinical Trial.

5

Evaluation of the effect of mericitabine at projected therapeutic and supratherapeutic doses on cardiac repolarization in healthy subjects: A thorough QT/QTc study.

Chen YC, Haznedar J, Kulkarni R, Vistuer C, Washington C, Liu M, Smith P. Chen YC, et al. Clin Pharmacol Drug Dev. 2014 May;3(3):179-86. doi: 10.1002/cpdd.79. Epub 2014 Feb 6. Clin Pharmacol Drug Dev. 2014. PMID: 27128607 Clinical Trial.

6

Single-dose pharmacokinetics of the HCV polymerase inhibitor mericitabine in healthy Caucasian and Japanese subjects.

Washington C, Moreira S, Haznedar J, Goelzer P, Chen YC. Washington C, et al. Among authors: chen yc. Drug Metab Pharmacokinet. 2014;29(2):141-7. doi: 10.2133/dmpk.dmpk-13-rg-016. Epub 2013 Sep 10. Drug Metab Pharmacokinet. 2014. PMID: 24025983 Free article. Clinical Trial.

7

Intrauterine Infusion and Hysteroscopic Injection of Autologous Platelet-Rich Plasma for Patients with a Persistent Thin Endometrium: A Prospective Case-Control Study.

Yu TN, Lee TH, Lee MS, Chen YC, Chen CI, Cheng EH, Lin PY, Huang CC, Lee CI. Yu TN, et al. Among authors: chen yc. J Clin Med. 2024 May 11;13(10):2838. doi: 10.3390/jcm13102838. J Clin Med. 2024. PMID: 38792379

8

Efficacy of Office-Based Salivary Ductal Steroid Irrigation for Managing Post-Irradiation Xerostomia in Head and Neck Cancer Patients: A Retrospective Study.

Chen YC, Viet-Nhi NK, Dang LH, Su CH, Hung SH. Chen YC, et al. Biomedicines. 2024 May 8;12(5):1033. doi: 10.3390/biomedicines12051033. Biomedicines. 2024. PMID: 38790995

9

The Efficacy and Safety of Tandem Transplant Versus Single Stem Cell Transplant for Multiple Myeloma Patients: A Systematic Review and Meta-Analysis.

Chen YH, Fogel L, Sun AY, Yang C, Patel R, Chang WC, Chen PH, Jhou HJ, Chen YC, Dai MS, Lee CH. Chen YH, et al. Among authors: chen yc. Diagnostics (Basel). 2024 May 16;14(10):1030. doi: 10.3390/diagnostics14101030. Diagnostics (Basel). 2024. PMID: 38786328 Free PMC article. Review.

10

Coronary CTA-based Vascular Radiomics Predicts Atherosclerosis Development Proximal to LAD Myocardial Bridging.

Chen YC, Zheng J, Zhou F, Tao XW, Chen Q, Feng Y, Su YY, Zhang Y, Liu T, Zhou CS, Tang CX, Weir-McCall J, Teng Z, Zhang LJ. Chen YC, et al. Eur Heart J Cardiovasc Imaging. 2024 May 23:jeae135. doi: 10.1093/ehjci/jeae135. Online ahead of print. Eur Heart J Cardiovasc Imaging. 2024. PMID: 38781436

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8,652 results

Search Page